Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Camlin Fine Sciences Ltd Regulatory Filings 2021

Jul 5, 2021

59255_rns_2021-07-05_76edfc50-e921-437d-a822-01bc44176b69.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [100 x 31] intentionally omitted <==

5[th] July, 2021

||To,BSE Limited,25, P. J. Towers,Dalal Street,Mumbai – 400 001**Ref:**Company Scrip Code: 532834|To,The Manager,Listing Department,National Stock Exchange of India Ltd.,Exchange Plaza, Bandra Kurla Complex,Bandra (East), Mumbai‐ 400051**Ref:Symbol:**CAMLINFINE||Series: EQ| |---|---|---|

Sub: Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter Ended June 30, 2021.

Dear Sir/Madam,

We hereby enclose the confirmation certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2021 received from Link Intime India Pvt. Ltd. (Registration Number INR000004058), Registrar and Share Transfer Agent of the Company.

Kindly take the above information on records.

Thanking You,

Encl.: a/a.

For Camlin Fine Sciences Limited

==> picture [55 x 52] intentionally omitted <==

==> picture [83 x 35] intentionally omitted <==

Mandar Godbole Company Secretary & Compliance Officer

==> picture [426 x 57] intentionally omitted <==